Examining controversies and new frontiers in lipid management

Stephen J. Nicholls

Research output: Contribution to journalReview article


Over the course of the last three decades our approach to the management of dyslipidemia has intensified on the basis of randomized controlled trials demonstrating reduction in cardiovascular events. However, the presence of a substantial residual risk and complex dyslipidemic states presents an ongoing challenge in clinical practice. The current controversies and opportunities in the management of both atherogenic and protective lipid factors will be reviewed.

Original languageEnglish
Pages (from-to)587-595
Number of pages9
JournalClinical Lipidology
Issue number5
Publication statusPublished - 1 Jan 2014


  • atherosclerosis
  • cardiovascular disease
  • lipids
  • risk factors

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Cardiology and Cardiovascular Medicine

Cite this